Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALMKT.PA
- Price
- 0.12
- Stock movement up
- +- (%)
- Company name
- Mauna Kea Technologies SAS
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Markedsværdi
- 8.77M
- Ent værdi
- -
- Pris/omsætning
- -
- Pris/bog
- -
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -
- Efterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års afkast
- -70.50%
- 3 års afkast
- -48.11%
- 5 års afkast
- -37.64%
- 10 års afkast
- -27.66%
Senest opdateret: 2025-09-15
UDBYTTE
ALMKT.PA betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | - |
| Pris til egenkapital | - |
| EV i forhold til salg | - |
ØKONOMI
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 0.11 |
| Daglig høj | 0.11 |
| Daglig lav | 0.10 |
| Daglig volumen | 9K |
| Højeste gennem alle tider | 17.75 |
| 1 års analytiker estimat | 1.00 |
| Beta | 1.07 |
| EPS (TTM) | - |
| Udbytte pr. aktie | - |
| Ex-div dato | - |
| Næste dato for resultatpræsentation | 2 Oct 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| ALMKT.PA | S&P500 | |
| Nuværende prisfald fra top notering | -99.41% | -0.80% |
| Højeste prisfald | -99.58% | -56.47% |
| Højeste efterår dato | 28 Apr 2025 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -78.42% | -10.99% |
| Gennemsnitlig tid til nyt højdepunkt | 723 days | 12 days |
| Maks. tid til nyt højdepunkt | 3612 days | 1805 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
8.77M
Markedsværdi kategori
Small-cap
Beskrivelse
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
Personale
65
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
France
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
PARIS & BOSTON, October 13, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
13. oktober 2025
PARIS & BOSTON, October 08, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
8. oktober 2025
PARIS & BOSTON, October 06, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT):
6. oktober 2025
PARIS, October 02, 2025--Regulatory News: Mauna Kea Technologies (Paris:ALMKT):
2. oktober 2025
PARIS & BOSTON, October 01, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
1. oktober 2025
PARIS & BOSTON, September 22, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), (the "Company") inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal lase...
22. september 2025
PARIS & BOSTON & SYDNEY, September 18, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) and Endotherapeutics, today announced that Cellvizio system has been included in the Austr...
18. september 2025
PARIS & BOSTON, September 12, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy...
12. september 2025
PARIS & BOSTON, September 08, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy...
8. september 2025
PARIS & BOSTON, July 28, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/n...
28. juli 2025
Næste side